GESTIÓN EN SALUD PÚBLICA: octubre 2021

Webex Events (classic) Registration is open for an AHRQ webinar on Nov. 16 from 1 to 2 p.m. ET to highlight the final Patient Narrative Item Set for the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Clinician & Group Survey. The narrative set consists of open-ended questions that enable survey users to collect comments from patients about their healthcare experiences. In this webinar, CAHPS researchers will present the narrative items for both the 3.0 and 4.0 versions of the Clinician & Group Survey and answer questions about using them. They will also preview Narrative Item Sets in development for the CAHPS Health Plan Survey and the Child HCAHPS Survey.

Acute care nurses' perceptions of leadership, teamwork, turnover intention and patient safety - a mixed methods study. | PSNet

The efficacy of mindful practice in improving diagnosis in healthcare: a systematic review and evidence synthesis. | PSNet

It's like sending a message in a bottle: a qualitative study of the consequences of one-way communication technologies in hospitals. | PSNet

Crafting Measures to Improve Accuracy of Stroke Diagnosis | Agency for Healthcare Research and Quality

Unmet family caregiver training needs associated with acute care utilization during home health care - PubMed

Systems Analysis of a Dedicated Ambulatory Respiratory Unit for Seeing and Ensuring Follow-up of Patients With COVID-19 Symptoms - PubMed

Diagnostic Errors in Pediatric Critical Care: A Systematic Review - PubMed

Designing a Patient Room as a Fall Protection Strategy: The Perspectives of Healthcare Design Experts - PubMed

National Trends In ED Visits, Hospital Admissions, And Mortality For Medicare Patients During The COVID-19 Pandemic - PubMed

Association of Race/Ethnicity and Social Determinants with Rehospitalization for Mental Health Conditions at Acute Care Children's Hospitals - PubMed

Data Infographics | Agency for Healthcare Research and Quality

STATISTICAL BRIEF #536: Trends in Health Insurance at Private Employers, 2008-2020

Home care nurses' identification of patients at risk of infection and their risk mitigation strategies: A qualitative interview study - PubMed

Impact of State Nurse Practitioner Regulations on Potentially Inappropriate Medication Prescribing Between Physicians and Nurse Practitioners: A National Study in the United States - PubMed

Using Standardized Videos to Examine the Validity of the Shared Decision Making Process Scale: Results of a Randomized Online Experiment - PubMed

Toward an asthma patient-reported outcome measure for use in digital remote monitoring - PubMed

The FTC Resurrects Its Penalty Offense Authority in a Big Way

Executive Order on Promoting Competition in the American Economy | The White House

Federal Register :: Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

What’s New for Biologics | FDA

Pharmaceutical Quality Symposium 2021: Innovations in a Changing World - 10/26/2021 - 10/27/2021 | FDA

Listening Session for Advanced Research Projects Agency for Health (ARPA-H) to be held 10/20

Inscripción al seminario web - Zoom

martes, 19 de octubre de 2021

FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans | FDA

COVID-19 protocols may remain important even for college campuses with 100% vaccine rates

Telehealth to the rescue for children’s mental health during COVID

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Study focuses on high COVID-19 risk in people with low-status jobs

Famous scientist joins NYU Langone’s Division of Rheumatology

Only 15% of unemployed adults in NC gained Medicaid coverage during the pandemic, finds study

Racial and ethnic minority cardiologists face discrimination, analysis reveals

Estado emocional y psicológico del personal de enfermería agredido durante la pandemia de COVID-19 en Latinoamérica

FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira | FDA

Studies Using Leftover, Deidentified Human Specimens Require IRB Review – Letter to Industry | FDA

Playbook for Threat Modeling Medical Devices Webinar - MDIC

FDA approves naloxone injection to counteract opioid overdoses | FDA

Videos Tell the Story of EvidenceNOW: Advancing Heart Health | Agency for Healthcare Research and Quality

The EvidenceNOW Model: Providing External Support for Primary Care | Agency for Healthcare Research and Quality

FDA Withdraws Temporary Hand Sanitizer Policies Effective December 31, 2021

lunes, 18 de octubre de 2021

Foodborne Illness - Causes, Symptoms and Prevention | STOP

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation - 10/20/2021 - 10/20/2021 | FDA

Notice of Updates | FDA

Notice of Updates | FDA Notice of Updates – FDA Recognized Antimicrobial Susceptibility Test Interpretive Criteria FDA Updates FDA recognizes, as of October 14, 2021, with certain exceptions, the standards published in: Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2021. Also, FDA recognizes in part the standards published in: Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Susceptibility Testing of Mycobacteria, Norcardia spp. and other Aerobic Actinomycetes. CLSI guideline M62- 1st Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. In addition, FDA updated recognition of the susceptibility test interpretive criteria (STIC) for azithromycin, cefazolin, cefiderocol, ceftolozane tazobactam, colistimethate, imipenem-cilastatin-relebactam, lefamulin, and polymyxin B. FDA has also removed telithromycin breakpoints as the drug has been withdrawn. For additional information about the FDA susceptibility test interpretive criteria recognition please visit http://www.fda.gov/STIC.